Skip to main content

Assessment and Management of Agitation

  • Living reference work entry
  • First Online:
Tasman’s Psychiatry

Abstract

Agitation is a major healthcare issue seen frequently in emergency and acute care settings and can be potentially harmful to patients, families, caregivers, and healthcare staff. Until recently, most interventions for agitation have focused on involuntary, forcibly injected medications for heavy sedation, and placement of affected individuals into physical restraints. Modern expert consensus, however, recommends a less coercive approach to quell agitation – using verbal de-escalation and other calming techniques, and voluntarily accepted medications – if this can be done safely. In this contemporary philosophy, restraints and forcible medications instead should be reserved only for those situations in which non-coercive alternatives have been exhausted. The major initial goals of agitation care should include the exclusion of severe medical etiologies for symptoms, and an empathetic, rapid stabilization of the acute crisis and distress, while longer-term interventions include creating a therapeutic alliance and effective continuing care to help prevent future episodes. This chapter details preferred methods of both the medical and psychiatric evaluations of agitation, as well as a comprehensive guide to de-escalation techniques, and describes current consensus best practice guidelines on psychopharmacologic approaches. In addition, there are sections on the pathophysiology of agitation, proper utilization (and avoidance when possible) of locked seclusion and physical restraints, agitation measurement scales, and important research findings and metrics related to the evaluation and treatment of agitated individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Administration TSAaMHS. (2003). Summary report: A national call to action: eliminating the use of seclusion and restraint.

    Google Scholar 

  • Allen, M. H. (2007). The organization of psychiatric emergency services and related differences in restraint practices. General Hospital Psychiatry, 29(6), 467–469.

    Google Scholar 

  • Allen, M. H., Carpenter, D., Sheets, J. L., Miccio, S., & Ross, R. (2003). What do consumers say they want and need during a psychiatric emergency? Journal of Psychiatric Practice, 9(1), 39–58.

    Google Scholar 

  • Allen, M. H., Currier, G. W., Carpenter, D., Ross, R. W., Docherty, J. P., & Expert Consensus Panel for Behavioral E. (2005). The expert consensus guideline series. Treatment of behavioral emergencies 2005. Journal of Psychiatric Practice, 11(Suppl 1), 5–108; quiz 10–2.

    Google Scholar 

  • Annas, G. J. (1999). The last resort – The use of physical restraints in medical emergencies. The New England Journal of Medicine, 341(18), 1408–1412.

    CAS  Google Scholar 

  • Barrett, J. A., Edinger, H., & Siegel, A. (1990). Intrahypothalamic injections of norepinephrine facilitate feline affective aggression via alpha 2-adrenoceptors. Brain Research, 525(2), 285–293.

    CAS  Google Scholar 

  • Battaglia, J. (2005). Pharmacologic management of acute agitation. Drugs, 65, 1207–1222.

    CAS  Google Scholar 

  • Beach, S. R., Celano, C. M., Sugrue, A. M., Adams, C., Ackerman, M. J., Noseworthy, P. A., et al. (2018). QT prolongation, Torsades de Pointes, and psychotropic medications: A 5-year update. Psychosomatics, 59(2), 105–122.

    Google Scholar 

  • Belkin, G. S. (2002). Self-restraint, self-examination: A historical perspective on restraints and ethics in psychiatry. Psychiatric Services, 53(6), 663–664.

    Google Scholar 

  • Berridge, C. W. (2008). Noradrenergic modulation of arousal. Brain Research Reviews, 58(1), 1–17.

    CAS  Google Scholar 

  • Berzlanovich, A. M., Schopfer, J., & Keil, W. (2012). Deaths due to physical restraint. Deutsches Arzteblatt International, 109, 27–32.

    Google Scholar 

  • Camm, A. J. (2012). Ziprasidone and the corrected QT interval: A comprehensive summary of clinical data. CNS Drugs, 26(4), 351–65.

    Google Scholar 

  • Campillo, A., Castillo, E., Vilke, G. M., Hopper, A., Ryan, V., & Wilson, M. P. (2015). First-generation antipsychotics are often prescribed in the emergency department but are often not administered with adjunctive medications. The Journal of Emergency Medicine, 49(6), 901–906.

    Google Scholar 

  • Cañas, F. (2007). Management of agitation in the acute psychotic patient – Efficacy without excessive sedation. European Neuropsychopharmacology, 17, S108–S114.

    Google Scholar 

  • Caracci, G., & Ananthamoorthy, R. (1999). Prolactin levels in premenopausal women treated with risperidone compared with those of women treated with typical neuroleptics. Journal of Clinical Psychopharmacology, 19, 194–196.

    CAS  Google Scholar 

  • Carmel, H., & Hunter, M. (1989). Staff injuries from inpatient violence. Hospital & Community Psychiatry, 40(1), 41–46.

    CAS  Google Scholar 

  • Citrome, L. (2011). Role of sublingual asenapine in treatment of schizophrenia. Neuropsychiatric Disease and Treatment, 7, 325–339.

    CAS  Google Scholar 

  • Citrome, L., & Volavka, J. (1999). Violent patients in the emergency setting. The Psychiatric Clinics of North America, 22(4), 789–801.

    CAS  Google Scholar 

  • Citrome, L., Landbloom, R., Chang, C. T., & Earley, W. (2017). Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder. Neuropsychiatric Disease and Treatment, 13, 2955–2963.

    CAS  Google Scholar 

  • Cole, J. B., Klein, L. R., Mullinax, S. Z., Nordstrom, K. D., Driver, B. E., & Wilson, M. P. (2019). Study enrollment when “Preconsent” is utilized for a randomized clinical trial of two treatments for acute agitation in the Emergency Department. Academic Emergency Medicine, 26(5), 559–566.

    Google Scholar 

  • Cuomo, A., Beccarini Crescenzi, B., Goracci, A., Bolognesi, S., Giordano, N., Rossi, R., et al. (2019). Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opinion on Drug Safety, 18(6), 455–463.

    CAS  Google Scholar 

  • Currier, G. W., Chou, J. C., Feifel, D., Bossie, C. A., Turkoz, I., Mahmoud, R. A., et al. (2004). Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. The Journal of Clinical Psychiatry, 65(3), 386–394.

    CAS  Google Scholar 

  • Currier, G. W., Trenton, A. J., Walsh, P. G., & van Wijngaarden, E. (2006). A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting. Journal of Psychiatric Practice, 12(4), 223–228.

    Google Scholar 

  • Currier, G. W., Walsh, P., & Lawrence, D. (2011). Physical restraints in the emergency department and attendance at subsequent outpatient psychiatric treatment. Journal of Psychiatric Practice, 17(6), 387–393.

    Google Scholar 

  • Day, R. K. (1999). Psychomotor agitation: poorly defined and badly measured. Journal of Affective Disorders, 55, 89–98.

    CAS  Google Scholar 

  • De Berardis, D., Fornaro, M., Orsolini, L., Iasevoli, F., Tomasetti, C., de Bartolomeis, A., et al. (2017). The role of inhaled Loxapine in the treatment of acute agitation in patients with psychiatric disorders: A clinical review. International Journal of Molecular Sciences, 18(2), 349.

    Google Scholar 

  • Department of Health and Human Services. (2006). Condition of participation: patient’s rights. Federal Register, 482(13), 71426–71428.

    Google Scholar 

  • Dolder, C. R., & Jeste, D. V. (2003). Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biological Psychiatry, 53(12), 1142–1145.

    CAS  Google Scholar 

  • Duhart, D. T. (2001). Violence in the workplace, 1993–99. Publication No. NCJ 190076. US Department of Justice Programs.

    Google Scholar 

  • Elgin, S. H. (1999). Language in emergency medicine: A verbal self-defense handbook. XLibris Corporation.

    Google Scholar 

  • Fishkind, A. (2002). Calming agitation with words, not drugs: 10 commandments for safety. Current Psychiatry, 1, 32–39. Available at: http://www.currentpsychiatry.com/pdf/0104/0104_Fishkind.pdf. Accessed June 13, 2011.

    Google Scholar 

  • Fishkind, A. (2008). Agitation II: De-escalation of the aggressive patient and avoiding coercion. In R. L. Glick, J. S. Berlin, A. B. Fishkind, et al. (Eds.), Emergency psychiatry: Principles and practice. Wolters Kluwer Health/Lippincott Williams & Wilkins.

    Google Scholar 

  • Forster, P. L., Cavness, C., & Phelps, M. A. (1999). Staff training decreases use of seclusion and restraint in an acute psychiatric hospital. Archives of Psychiatric Nursing, 13, 269–271.

    CAS  Google Scholar 

  • Frueh, B. C., Knapp, R. G., & Cusack, K. J. (2005). Patient’s reports of traumatic or harmful experiences within the psychiatric setting. Psychiatric Services, 56, 1123–1133.

    Google Scholar 

  • Garriga, M., Pacchiarotti, I., Kasper, S., Zeller, S. L., Allen, M. H., Vazquez, G., et al. (2016). Assessment and management of agitation in psychiatry: expert consensus. The World Journal of Biological Psychiatry, 17(2), 86–128.

    Google Scholar 

  • Gates, D. M., Ross, C. S., & McQueen, L. (2006). Violence against emergency department workers. The Journal of Emergency Medicine, 31(3), 331–337.

    Google Scholar 

  • Gault, T. I., Gray, S. M., Vilke, G. M., & Wilson, M. P. (2012). Are oral medications effective in the management of acute agitation? The Journal of Emergency Medicine, 43(5), 854–859.

    Google Scholar 

  • Gaynes, B. N., Brown, C. L., Lux, L. J., Brownley, K. A., Van Dorn, R. A., Edlund, M. J., et al. (2017). Preventing and de-escalating aggressive behavior among adult psychiatric patients: a systematic review of the evidence. Psychiatric Services, 68(8), 819–831.

    Google Scholar 

  • Gerlach, J., & Larsen, E. B. (1999). Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatrica Scandinavica, 99, 113–117.

    Google Scholar 

  • Gordon, H., Hindley, N., Marsden, A., & Shivayogi, M. (1999). The use of mechanical restraint in the management of psychiatric patients: Is it ever appropriate? The Journal of Forensic Psychiatry, 10(1), 173–186.

    Google Scholar 

  • Haimowitz, S., Urff, J., & Huckshorn, K. A. (2006). Restraint and seclusion – A risk management guide. National Association of State Mental Health Program Directors Web site. Available from: http://www.nasmhpd.org/docs/publications/docs/2008/SRBriefings/I_3_I_B_MngtGuideAttorneys.pdf.

  • Hall, R. C., Gardner, E. R., Popkin, M. K., Lecann, A. F., & Stickney, S. K. (1981). Unrecognized physical illness prompting psychiatric admission: A prospective study. The American Journal of Psychiatry, 138(5), 629–635.

    CAS  Google Scholar 

  • Holloman, G. H., Jr., & Zeller, S. L. (2012). Overview of project BETA: Best practices in evaluation and treatment of agitation. The Western Journal of Emergency Medicine, 13(1), 1–2.

    Google Scholar 

  • Howes, O. D., & Kapur, S. (2009). The dopamine hypothesis of schizophrenia: Version III – the final common pathway. Schizophrenia Bulletin, 35(3), 549–562.

    Google Scholar 

  • Huf, G., Coutinho, E. S., Adams, C. E., & Group TC. (2007). Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine. BMJ, 335(7625), 869.

    CAS  Google Scholar 

  • Huf, G., Alexander, J., Allen, M. H., & Raveendran, N. S. (2009). Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database of Systematic Reviews, 3, Art. No.: CD005146.

    Google Scholar 

  • Keck, P. E., & McElroy, S. L. (2002). Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications. The Journal of Clinical Psychiatry, 63(suppl 4), 3–11.

    CAS  Google Scholar 

  • Kinon, B. J., Gilmore, J. A., Liu, H., & Halbreich, U. M. (2003). Hyperprolactinemia in response to antipsychotic drugs: Characterization across comparative clinical trials. Psychoneuroendocrinology, 28(Suppl 2), 69–82.

    CAS  Google Scholar 

  • Knox, D. K., & Holloman, G. H. (2012). Use and avoidance of seclusion and restraint: consensus statement of the American Association for Emergency Psychiatry Project BETA seclusion and restraint workgroup. The Western Journal of Emergency Medicine, 13(1), 35–40.

    Google Scholar 

  • Lam, L. T. (2002). Aggression exposure and mental health among nurses. Australian e-Journal for the Advances Mental Health, 1, 89–100.

    Google Scholar 

  • Lazare, A., & Levy, R. S. (2011). Apologizing for humiliations in medical practice. Chest, 139(4), 746–751.

    Google Scholar 

  • Lesem, M. D., Tran-Johnson, T. K., Riesenberg, R. A., Feifel, D., Allen, M. H., Fishman, R., et al. (2011). Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. The British Journal of Psychiatry, 198(1), 51–58.

    Google Scholar 

  • Lindenmayer, J. P. (2000). The pathophysiology of agitation. The Journal of Clinical Psychiatry, 61(suppl 14), 5–10.

    CAS  Google Scholar 

  • MacDonald, K., Wilson, M. P., Minassian, A., Vilke, G. M., Perez, R., Cobb, P., et al. (2010). A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients. General Hospital Psychiatry, 32(4), 443–445.

    Google Scholar 

  • MacDonald, K., Wilson, M., Minassian, A., Vilke, G. M., Becker, O., Tallian, K., et al. (2012). A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation. Journal of Clinical Psychopharmacology, 32(3), 317–322.

    CAS  Google Scholar 

  • Mallikaarjun, S., Shoaf, S. E., Boulton, D. W., & Bramer, S. L. (2008). Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole. Clinical Pharmacokinetics, 47(8), 533–542.

    CAS  Google Scholar 

  • Martinez-Raga, J., Amore, M., Di Sciascio, G., Florea, R. I., Garriga, M., Gonzalez, G., et al. (2018). 1st international experts’ meeting on agitation: conclusions regarding the current and ideal management paradigm of agitation. Frontiers in Psychiatry, 9, 54.

    Google Scholar 

  • McCue, R. E., Urcuyo, L., & Lilu, Y. (2004). Reducing restraint use in a public psychiatric inpatient service. The Journal of Behavioral Health Services & Research, 31, 217–224.

    Google Scholar 

  • Miner, J. R., Klein, L. R., Cole, J. B., Driver, B. E., Moore, J. C., & Ho, J. D. (2018). The characteristics and prevalence of agitation in an Urban County Emergency Department. Annals of Emergency Medicine, 72(4), 361–370.

    Google Scholar 

  • Mullinax, S., Shokraneh, F., Wilson, M. P., & Adams, C. E. (2017). Oral medication for agitation of psychiatric origin: A scoping review of randomized controlled trials. The Journal of Emergency Medicine, 53(4), 524–529.

    Google Scholar 

  • Nordstrom, K. (2009). Inhaled loxapine for acute agitation. Future Neurology, 4, 539–545.

    CAS  Google Scholar 

  • Nordstrom, K., & Allen, M. H. (2007). Managing the acutely agitated and psychotic patient. CNS Spectrums, 12(10 Suppl 17), 5–11.

    Google Scholar 

  • Nordstrom, K., & Wilson, M. P. (Eds.). (2018). Quick guide to psychiatric emergencies: Tools for behavioral and toxicological situations. Springer International Publishing.

    Google Scholar 

  • Nordstrom, K., Zun, L. S., Wilson, M. P., Stiebel, V., Ng, A. T., Bregman, B., et al. (2012). Medical evaluation and triage of the agitated patient: consensus statement of the American Association for emergency psychiatry project beta medical evaluation workgroup. The Western Journal of Emergency Medicine, 13(1), 3–10.

    Google Scholar 

  • Ostinelli, E. G., Brooke-Powney, M. J., Li, X., & Adams, C. E. (2017). Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database of Systematic Reviews, 7, CD009377.

    Google Scholar 

  • Ostinelli, E. G., Jajawi, S., Spyridi, S., Sayal, K., & Jayaram, M. B. (2018). Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database of Systematic Reviews, 1, CD008074.

    Google Scholar 

  • Pacciardi, B., Calcedo, A., & Messer, T. (2019). Inhaled Loxapine for the management of acute agitation in bipolar disorder and schizophrenia: Expert review and commentary in an era of change. Drugs R D., 19(1), 15–25.

    CAS  Google Scholar 

  • Polcwiartek, C., Sneider, B., Graff, C., Taylor, D., Meyer, J., Kanters, J. K., et al. (2015). The cardiac safety of aripiprazole treatment in patients at high risk for torsade: A systematic review with a meta-analytic approach. Psychopharmacology, 232(18), 3297–3308.

    CAS  Google Scholar 

  • Powney, M. J., Adams, C. E., & Jones, H. (2012). Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database of Systematic Reviews, 11, CD009377.

    Google Scholar 

  • Pratts, M., Citrome, L., Grant, W., Leso, L., & Opler, L. A. (2014). A single-dose, randomized, double-blind, placebo-controlled trial of sublingual asenapine for acute agitation. Acta Psychiatrica Scandinavica, 130(1), 61–68.

    CAS  Google Scholar 

  • Preval, H., Klotz, S. G., Southard, R., & Francis, A. (2005). Rapid-acting IM ziprasidone in a psychiatric emergency service: A naturalistic study. General Hospital Psychiatry, 27(2), 140–144.

    Google Scholar 

  • Rappaport, B. A. (2008). FDA response to droperidol black box warning editorials. Anesthesia and Analgesia, 106, 1585.

    Google Scholar 

  • Raveendran, N. S., Tharyan, P., Alexander, J., Adams, C. E., & Group TR-IIC. (2007). Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ, 335(7625), 865.

    CAS  Google Scholar 

  • Recupero, P. R., Price, M., Garvey, K. A., Daly, B., & Xavier, S. L. (2011). Restraint and seclusion in psychiatric treatment settings: regulation, case law, and risk management. The Journal of the American Academy of Psychiatry and the Law, 39, 465–476.

    Google Scholar 

  • Richards, J. R., & Schneir, A. B. (2003). Droperidol in the Emergency Department: Is it safe? The Journal of Emergency Medicine, 24(4), 441–447.

    Google Scholar 

  • Richmond, J. S., Berlin, J. S., Fishkind, A. B., Holloman, G. H., Jr., Zeller, S. L., Wilson, M. P., et al. (2012). Verbal de-escalation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA de-escalation workgroup. The Western Journal of Emergency Medicine, 13(1), 17–25.

    Google Scholar 

  • Ries, R., & Sayadipour, A. (2014). Management of psychosis and agitation in medical-surgical patients who have or are at risk for prolonged QT interval. Journal of Psychiatric Practice, 20(5), 338–344.

    Google Scholar 

  • Rogers, C. R. (1957). The necessary and sufficient conditions of therapeutic personality change. Journal of Consulting Psychology, 21(2), 95–103.

    CAS  Google Scholar 

  • Sacchetti, E., Amore, M., Di Sciascio, G., Ducci, G., Girardi, P., Mauri, M., et al. (2017). Psychomotor agitation in psychiatry: an Italian expert consensus. Evidence-Based Psychiatric Care, 1, 1–24.

    Google Scholar 

  • Sachs, G. S. (2006). A review of agitation in mental illness: burden of illness and underlying pathology. The Journal of Clinical Psychiatry, 67(Suppl 10), 5–12.

    Google Scholar 

  • San, L., Marksteiner, J., Zwanzger, P., Figuero, M. A., Romero, F. T., Kyropoulos, G., et al. (2016). State of acute agitation at psychiatric emergencies in Europe: the STAGE study. Clinical Practice and Epidemiology in Mental Health, 12, 75–86.

    Google Scholar 

  • Schneider, A., Mullinax, S., Hall, N., Acheson, A., Oliveto, A., & Wilson, M. P. (2021 Aug). Intramuscular agitation for treatment of agitation in the emergency department: A systematic review of controlled trials. The American Journal of Emergency Medicine, 46, 193–199.

    Google Scholar 

  • Siegel, A., Roeling, T. A., Gregg, T. R., & Kruk, M. R. (1999). Neuropharmacology of brain-stimulation-evoked aggression. Neuroscience and Biobehavioral Reviews, 23(3), 359–389.

    CAS  Google Scholar 

  • Smith, M. J. (1975). When I Say No, I Feel Guilty: How To Cope – Using the skills of systematic assertive therapy. Dial Press/Bantum Books.

    Google Scholar 

  • Smith, G. M., Davis, R. H., Bixler, E. O., Lin, H. M., Altenor, A., Altenor, R. J., et al. (2005). Pennsylvania State Hospital system’s seclusion and restraint reduction program. Psychiatric Services, 56(9), 1115–1122.

    Google Scholar 

  • Smith, G. M., Ashbridge, D. M., Davis, R. H., & Steinmetz, W. (2015). Correlation between reduction of seclusion and restraint and assaults by patients in Pennsylvania’s state hospitals. Psychiatric Services, 66(3), 303–309.

    Google Scholar 

  • Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., et al. (2017). Safety, tolerability, and risks associated with first- and second-generation antipsychotics: A state-of-the-art clinical review. Therapeutics and Clinical Risk Management, 13, 757–777.

    CAS  Google Scholar 

  • Stowell, K. R., Florence, P., Harman, H. J., & Glick, R. L. (2012). Psychiatric evaluation of the agitated patient: Consensus statement of the American Association for emergency psychiatry project beta psychiatric evaluation workgroup. The Western Journal of Emergency Medicine, 13(1), 11–16.

    Google Scholar 

  • Swift, R. H., Harrigan, E. P., Cappelleri, J. C., Kramer, D., & Chandler, L. P. (2002). Validation of the behavioural activity rating scale (BARS): a novel measure of activity in agitated patients. Journal of Psychiatric Research, 36(2), 87–95.

    CAS  Google Scholar 

  • Vieta, E., & Montes, J. M. (2018). A review of asenapine in the treatment of bipolar disorder. Clinical Drug Investigation, 38(2), 87–99.

    CAS  Google Scholar 

  • Vieta, E., Garriga, M., Cardete, L., Bernardo, M., Lombrana, M., Blanch, J., et al. (2017). Protocol for the management of psychiatric patients with psychomotor agitation. BMC Psychiatry, 17(1), 328.

    Google Scholar 

  • Vilke, G. M., Bozeman, W. P., Dawes, D. M., Demers, G., & Wilson, M. P. (2012). Excited delirium syndrome (ExDS): treatment options and considerations. Journal of Forensic and Legal Medicine, 19(3), 117–121.

    Google Scholar 

  • Williams, A. M. (2018). Coadministration of intramuscular olanzapine and benzodiazepines in agitated patients with mental illness. Mental Health Clinic, 8(5), 208–213.

    Google Scholar 

  • Wilson, M. P. (2019). Acute agitation. In J. E. Tintinalli, O. J. Ma, D. Yealy, G. D. Meckler, & J. S. Stapyczynski (Eds.), Tintinalli’s emergency medicine: A comprehensive study guide (9th ed.). McGraw Hill.

    Google Scholar 

  • Wilson, M. P., & Sloane, C. (2012). Chemical restraints, physical restraints, and other demonstrations of force. In J. Jesus, P. Rosen, J. Adams, A. Derse, R. Wolfe, & S. Grossman (Eds.), Ethical problems in emergency medicine: A discussion-based review (pp. 139–148). Wiley-Blackwell.

    Google Scholar 

  • Wilson, M. P., Pepper, D., Currier, G. W., Holloman, G. H., Jr., & Feifel, D. (2012a). The psychopharmacology of agitation: consensus statement of the American Association for emergency psychiatry project beta psychopharmacology workgroup. The Western Journal of Emergency Medicine, 13(1), 26–34.

    Google Scholar 

  • Wilson, M. P., Chen, N., Vilke, G. M., Castillo, E. M., MacDonald, K. S., & Minassian, A. (2012b). Olanzapine in ED patients: Differential effects on oxygenation in patients with alcohol intoxication. The American Journal of Emergency Medicine, 30(7), 1196–1201.

    Google Scholar 

  • Wilson, M. P., MacDonald, K., Vilke, G. M., & Feifel, D. (2012c). Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients. The Journal of Emergency Medicine, 43(5), 889–896.

    Google Scholar 

  • Wilson, M. P., MacDonald, K., Vilke, G. M., & Feifel, D. (2012d). A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation. The Journal of Emergency Medicine, 43(5), 790–797.

    Google Scholar 

  • Wilson, M. P., MacDonald, K., Vilke, G. M., Ronquillo, L., & Feifel, D. (2013). Intramuscular ziprasidone: Influence of alcohol and benzodiazepines on vital signs in the emergency setting. The Journal of Emergency Medicine, 45(6), 901–908.

    Google Scholar 

  • Wilson, M. P., Nordstrom, K., Shah, A. A., & Vilke, G. M. (2015). Psychiatric emergencies in pregnant women. Emergency Medicine Clinics of North America, 33(4), 841–851.

    Google Scholar 

  • Wilson, M. P., Nordstrom, K., Hopper, A., Porter, A., Castillo, E. M., & Vilke, G. M. (2017). Risperidone in the emergency setting is associated with more hypotension in elderly patients. The Journal of Emergency Medicine, 53(5), 735–739.

    Google Scholar 

  • Zareifopoulos, N., & Panayiotakopoulos, G. (2019). Treatment Options for Acute Agitation in Psychiatric Patients: Theoretical and Empirical Evidence. Cureus, 11(11), e6152.

    Google Scholar 

  • Zeller, S. L. (2010). Treatment of psychiatric patients in emergency settings. Primary Psychiatry, 17, 35–41.

    Google Scholar 

  • Zeller, S. L., & Rhoades, R. W. (2010). Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clinical Therapeutics, 32(3), 403–425.

    CAS  Google Scholar 

  • Zeller, S. L., & Wilson, M. P. (2011). Acute treatment of agitation in schizophrenia. Drug Discovery Today: Therapeutic Strategies., 8(1–2), 25–29.

    CAS  Google Scholar 

  • Zeller, S. L., Holloman, G. H., & Wilson, M. P. (2014). Management of agitation. In A. Tasman, J. Lieberman, J. Kay, M. First, & M. Riba (Eds.), Psychiatry (4th ed.). Wiley Publishing.

    Google Scholar 

  • Zeller, S. L., Nordstrom, K. D., & Wilson, M. P. (2017). The diagnosis and management of agitation. Cambridge, 281 p.

    Google Scholar 

  • Zun, L. S. (2003). A prospective study of the complication rate of use of patient restraint in the emergency department. The Journal of Emergency Medicine, 24(2), 119–124.

    Google Scholar 

  • Zun, L. S. (2018). Evidence-based review of pharmacotherapy for acute agitation. Part 1: Onset of efficacy. The Journal of Emergency Medicine, 54(3), 364–374.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Zeller, S.L., Wilson, M.P., Pacciardi, B. (2023). Assessment and Management of Agitation. In: Tasman, A., et al. Tasman’s Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-030-42825-9_5-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-42825-9_5-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-42825-9

  • Online ISBN: 978-3-030-42825-9

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics